These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 15982324)
1. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Thasler WE; Schlott T; Thelen P; Hellerbrand C; Bataille F; Lichtenauer M; Schlitt HJ; Jauch KW; Weiss TS Histopathology; 2005 Jul; 47(1):57-66. PubMed ID: 15982324 [TBL] [Abstract][Full Text] [Related]
2. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. Körner M; Hayes GM; Rehmann R; Zimmermann A; Scholz A; Wiedenmann B; Miller LJ; Reubi JC J Hepatol; 2006 Dec; 45(6):825-35. PubMed ID: 16935383 [TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Sasaki M; Nakanuma Y; Ho SB; Kim YS Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202 [TBL] [Abstract][Full Text] [Related]
5. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas. Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664 [TBL] [Abstract][Full Text] [Related]
6. High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas. Fiorentino M; D'Errico A; Altimari A; Barozzi C; Grigioni WF Diagn Mol Pathol; 1999 Dec; 8(4):189-94. PubMed ID: 10617275 [TBL] [Abstract][Full Text] [Related]
7. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356 [TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver. Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969 [TBL] [Abstract][Full Text] [Related]
9. Tricellulin expression and its prognostic significance in primary liver carcinomas. Somorácz A; Korompay A; Törzsök P; Patonai A; Erdélyi-Belle B; Lotz G; Schaff Z; Kiss A Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413 [TBL] [Abstract][Full Text] [Related]
10. Annexin A1: A new immunohistological marker of cholangiocarcinoma. Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714 [TBL] [Abstract][Full Text] [Related]
13. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651 [TBL] [Abstract][Full Text] [Related]
14. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis. Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638 [TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma. Sabit H; Tsuneyama K; Shimonishi T; Harada K; Cheng J; Ida H; Saku T; Saito K; Nakanuma Y Pathol Int; 2001 Apr; 51(4):248-56. PubMed ID: 11350606 [TBL] [Abstract][Full Text] [Related]
16. MiR-126 in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: A Reappraisal with an Zailaie SA; Sergi CM Ann Clin Lab Sci; 2022 Jan; 52(1):73-85. PubMed ID: 35181620 [TBL] [Abstract][Full Text] [Related]
17. Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma. Yu HY; Xiang DR; Huang HJ; Li J; Sheng JF Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):492-8. PubMed ID: 20943458 [TBL] [Abstract][Full Text] [Related]
18. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722 [TBL] [Abstract][Full Text] [Related]
19. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [TBL] [Abstract][Full Text] [Related]
20. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Gramantieri L; Giovannini C; Lanzi A; Chieco P; Ravaioli M; Venturi A; Grazi GL; Bolondi L Liver Int; 2007 Sep; 27(7):997-1007. PubMed ID: 17696940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]